Cases of metastatic prostate cancer are on the rise since the U.S. Preventive Services Task Force (USPSTF) recommended against routine PSA (prostate specific antigen) screening in men over age 75 in
Deadly Prostate Cancer on the Rise
Recent study findings come as no surprise to many experts
